Search Result "monoclonal antbody"


4Aβ1-15-Derived Monoclonal Antibody Reduces More Aβ Burdens and Neuroinflammation than Homologous Vaccine in APP/PS1 Mice

Journal: Current Alzheimer Research
Volume: 12 Issue: 4 Year: 2015 Page: 384-397
Author(s): Yuwei Zhang,Juntao Zou,Junhua Yang,Zhibin Yao

Update on the Use of Biologics in Lupus

Journal: Current Pharmaceutical Biotechnology
Volume: 15 Issue: 6 Year: 2014 Page: 516-520
Author(s): Manisha Relan,Sahana Vishwanath,Long Shen,Julian L. Ambrus Jr

Eph Receptors as Drug Targets: Single-Chain Antibodies and Beyond

Journal: Current Drug Targets
Volume: 16 Issue: 10 Year: 2015 Page: 1021-1030
Author(s): Urpo Lamminmaki,Dimitar Nikolov,Juha Himanen

Research Article

Effect of Number of Bifunctional Chelating Agents on the Pharmacokinetics and Immunoreactivity of 177Lu-labeled Rituximab: A Systemic Study

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2018 Page: 146-153
Author(s): Mohini Guleria,Tapas Das,Chandan Kumar,Rohit Sharma,Jeyachitra Amirdhanayagam,Haladhar D. Sarma,Ashutosh Dash

Review Article

ADCs, as Novel Revolutionary Weapons for Providing a Step Forward in Targeted Therapy of Malignancies

Journal: Current Drug Delivery
Volume: 17 Issue: 1 Year: 2020 Page: 23-51
Author(s): Nooshafarin Amani,Farid Abedin Dorkoosh,Hamid Mobedi

Therapeutic Implications of Tocilizumab, A Humanized Anti-Interleukin-6 Receptor Antibody, for Various Immune-Mediated Diseases: An Update Review

Journal: Current Rheumatology Reviews
Volume: 8 Issue: 3 Year: 2012 Page: 209-226
Author(s): Toshio Tanaka,Atsushi Ogata,Yoshihito Shima,Masashi Narazaki,Atsushi Kumanogoh,Tadamitsu Kishimoto

Review Article

PCSK9 Inhibitors and Cardiovascular Disease: Impact on Cardiovascular Outcomes

Journal: Current Drug Discovery Technologies
Volume: 17 Issue: 2 Year: 2020 Page: 138-146
Author(s): Paraskevi Farmaki,Christos Damaskos,Nikolaos Garmpis,Anna Garmpi,Spyridon Savvanis,Evangelos Diamantis

General Review Article

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors, Reality or Dream in Managing Patients with Cardiovascular Disease

Journal: Current Drug Metabolism
Volume: 20 Issue: 1 Year: 2019 Page: 72-82
Author(s): Mohammad Alkhalil

Anti-IgE Therapy with Omalizumab for Severe Asthma: Current Concepts and Potential Developments

Journal: Current Drug Targets
Volume: 16 Issue: 2 Year: 2015 Page: 171-178
Author(s): Girolamo Pelaia,Alessandro Vatrella,Maria Teresa Busceti,Luca Gallelli,Rosa Terracciano,Rosario Maselli

Inhibition of the VEGF/VEGFR Pathway Improves Survival in Advanced Kidney Cancer: A Systematic Review and Meta-Analysis

Journal: Current Drug Targets
Volume: 16 Issue: 2 Year: 2015 Page: 164-170
Author(s): Roberto Iacovelli,Cora N. Sternberg,Camillo Porta,Elena Verzoni,Filippo de Braud,Bernard Escudier,Giuseppe Procopio

Previous   Next

Go To   Results 1 - 1 of 139

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy